Biotronik Introduces Pulsar-18 T3 Triaxial 4-F Stent System

 

January 22, 2019—Biotronik launched the Pulsar-18 T3 triaxial stent system at LINC 2019, the Leipzig Interventional Course held January 22–25 in Leipzig, Germany. The device is indicated for use in patients with atherosclerotic disease of the superficial femoral, proximal popliteal, and infrapopliteal arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA; eg, residual stenosis and dissection).

According to the company, the Pulsar-18 T3 system combines three technologies to improved implantation procedure: (1) the 4-F low profile decreases the risk of access site complications and reduces the need for closure devices compared with 6-F size; (2) the triaxial shaft design facilitates stable and accurate implantation of the clinically proven Pulsar stent; and (3) the intuitive and ergonomic wheel-operated handle simplifies handling during the procedure for physicians.

The device provides efficient delivery of stents up to 200 mm. The thin struts, low chronic outward force, and high multidirectional flexibility of the Pulsar stent ensure conformability and support to the vessel in all natural vessel movements, stated Biotronik.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.